In the comment by Fraser et al. (1) to our report (2), several issues were raised that were not settled in our study. The first problem is the persistence (into adulthood) of the insulin resistance generated by intrauterine growth retardation (defined as small for gestational age [SGA]) and its potential for nonalcoholic fatty liver disease (NAFLD). Very-low birth weight confers an increased susceptibility to insulin resistance and metabolic diseases in adulthood (3) that are not attributable to body size composition or fat distribution. In adults born SGA, liver fat deposition and altered liver function tests may be part of a central axis of abdominal obesity. Dual-energy X-ray absorptiometry documented a moderately higher degree of abdominal obesity in young men born SGA, independently of BMI and waist-to-hip ratio, associated with an impairment of the insulin-stimulated glycolytic flux and a reduced forearm (muscle) glucose uptake in the face of normal whole-body glucose uptake (4). Ectopic fat accumulation in adults born SGA may thus derive from an abnormal function of the adipose tissue—suggested by hypoleptinemia—compared with individuals with normal weight at birth, even after correction for fat mass, sex, and hyperinsulinemia (5).

A second issue is a possible sex difference in the risk of NAFLD associated with several variables. On the basis of indirect evidence, we have previously speculated that the circulating levels of estrogens within the physiologic range might be responsible for a “protective” effect on the development of steatosis (due to both NAFLD and, presumably, virus-related steatosis [6]). This would imply that, similar to what happens in cardiovascular disease, women in the fertile age are more spared than men from the development of steatosis and that this protection vanes after menopause. Whether this also happens in SGA steatosis and NAFLD occurring in childhood remains to be determined. The relatively small size in our cohort does not allow a robust analysis in relation to sex. Whereas in male subjects, the association of SGA with NAFLD is maintained (odds ratio 9.59 [95% CI 2.52–36.52]), the association is no longer significant in female subjects (4.21 [0.58–30.66]), but <25% of our NAFLD female subjects were in the postpubertal age.

1.
Fraser A, Ebrahim S, Ben-Shlomo Y, Davey Smith G, Lawlor DA: Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children (Letter).
Diabetes Care
30
:
e124
,
2007
. DOI: 10.2337/dc07-1246
2.
Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, Bugianesi E: Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children.
Diabetes Care
30
:
2638
–2640,
2007
3.
Hovi P, Andersson S, Eriksson JG, Jarvenpaa AL, Strang-Karlsson S, Makitie O, Kajantie E: Glucose regulation in young adults with very low birth weight.
N Engl J Med
356
:
2053
–2063,
2007
4.
Vaag A, Jensen CB, Poulsen P, Brons C, Pilgaard K, Grunnet L, Vielwerth S, Alibegovic A: Metabolic aspects of insulin resistance in individuals born small for gestational age.
Horm Res
65(Suppl. 3)
:
137
–143,
2006
5.
Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C: Relatively low serum leptin levels in adults born with intra-uterine growth retardation.
Int J Obes Relat Metab Disord
25
:
491
–495,
2001
6.
Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P: Gender, fatty liver and GGT.
Hepatology
44
:
278
–279,
2006